Several tumor components (cancer cells, cancer-associated fibroblasts, or immune cells) are capable of secreting S100A4, highlighting that its pro-tumorigenicity may be mediated by its inclusion in sEV cargo (51, 52). This evidence concerns the gene S100A4 and neoplasm.